Haematologica (Feb 2018)
Outcomes after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia harboring t(7;11)(p15;p15)
- Kaito Harada,
- Noriko Doki,
- Jun Aoki,
- Jinichi Mori,
- Shinichiro Machida,
- Masayoshi Masuko,
- Naoyuki Uchida,
- Yuho Najima,
- Takahiro Fukuda,
- Heiwa Kanamori,
- Hiroyasu Ogawa,
- Shuichi Ota,
- Kazuei Ogawa,
- Satoshi Takahashi,
- Masanobu Kasai,
- Akio Maeda,
- Koji Nagafuji,
- Toshiro Kawakita,
- Tatsuo Ichinohe,
- Yoshiko Atsuta
Affiliations
- Kaito Harada
- Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Tokyo, Japan
- Noriko Doki
- Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
- Jun Aoki
- Department of Hematology, Kanagawa Cancer Center, Yokohama, Tokyo, Japan
- Jinichi Mori
- Department of Hematology, Jyoban Hospital, Tokiwakai, Fukushima, Tokyo, Japan
- Shinichiro Machida
- Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Tokyo, Japan
- Masayoshi Masuko
- Department of Stem Cell Transplantation, Niigata University Hospital, Tokyo, Japan
- Naoyuki Uchida
- Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan
- Yuho Najima
- Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
- Takahiro Fukuda
- Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
- Heiwa Kanamori
- Department of Hematology, Kanagawa Cancer Center, Yokohama, Tokyo, Japan
- Hiroyasu Ogawa
- Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan
- Shuichi Ota
- Department of Hematology, Sapporo Hokuyu Hospital, University of Tokyo, Japan
- Kazuei Ogawa
- Department of Hematology, Fukushima Medical University Hospital, University of Tokyo, Japan
- Satoshi Takahashi
- Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, University of Tokyo, Japan
- Masanobu Kasai
- Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Kurume University Hospital, Japan
- Akio Maeda
- Department of Hematology, Hyogo Cancer Center, Kurume University Hospital, Japan
- Koji Nagafuji
- Division of Hematology and Oncology, Department of Medicine, Kurume University Hospital, Japan
- Toshiro Kawakita
- Department of Hematology, National Hospital Organization Kumamoto Medical Center, Hiroshima University, Japan
- Tatsuo Ichinohe
- Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan
- Yoshiko Atsuta
- Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya University Graduate School of Medicine, Japan;Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Japan
- DOI
- https://doi.org/10.3324/haematol.2017.179804
- Journal volume & issue
-
Vol. 103,
no. 2
Abstract
No abstracts available.